Findings indicate that altering glucose metabolism in T cells boosts their therapeutic potential against melanoma, paving the ...
A breast cancer diagnosis often arrives as a profound turning point, bringing uncertainty and complex emotions. While the ...
The same mRNA technology behind COVID-19 vaccines is now being used in the fight against cancer, and the University of ...
Explore how cfDNA levels change around colorectal cancer surgery and their potential as non-invasive biomarkers for ...
Cancer accounted for nearly 10 million deaths in 2020—almost one in every six deaths globally—according to the World Health Organization. Because the detection of abnormal diseased cellular growth ...
The methylation of plasma cell-free DNA (cfDNA) has emerged as a valuable diagnostic and prognostic biomarker in various cancers including colorectal cancer (CRC). Currently, there are no biomarkers ...
Proliferating cells, in particular tumor cells, express a dimeric isoenzyme of pyruvate kinase, termed Tumor M2 pyruvate kinase. In the last few years, much attention has been paid to this novel ...
Proteins drive cell behavior and are the direct targets of many new cancer drugs, especially antibody-drug conjugates (ADCs) ...
Cancer accounted for nearly 10 million deaths in 2020 – almost one in every six deaths globally – according to the World ...
In patients with RCC, exceptional response to immunotherapy may be related to clonal neoantigen-driven cytotoxic T-cell ...